June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Investigation into the ability of Preferential Hyperacuity Perimetry (PHP) to detect reactivation of neovascularisation in patients undergoing ranibizumab injections for age-related macular degeneration (AMD)
Author Affiliations & Notes
  • Stephanie Mroczkowska
    Ophthalmic Research Group, Aston University, Birmingham, United Kingdom
  • Antonio Calcagni
    Ophthalmic Research Group, Aston University, Birmingham, United Kingdom
    Birmingham and Midland Eye Centre, Birmingham, United Kingdom
  • Jonathan Gibson
    Ophthalmic Research Group, Aston University, Birmingham, United Kingdom
  • Usha Chakravarthy
    Centre for Vision and Vascular Science, Queen's University Belfast, Belfast, Ireland
  • Ruth Hogg
    Centre for Vision and Vascular Science, Queen's University Belfast, Belfast, Ireland
  • Footnotes
    Commercial Relationships Stephanie Mroczkowska, Novartis (F); Antonio Calcagni, None; Jonathan Gibson, None; Usha Chakravarthy, Bayer (C), Novartis (F), Neovista (C), Oraya (F); Ruth Hogg, Novartis (F), Novartis (C)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 4153. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Stephanie Mroczkowska, Antonio Calcagni, Jonathan Gibson, Usha Chakravarthy, Ruth Hogg, ; Investigation into the ability of Preferential Hyperacuity Perimetry (PHP) to detect reactivation of neovascularisation in patients undergoing ranibizumab injections for age-related macular degeneration (AMD). Invest. Ophthalmol. Vis. Sci. 2013;54(15):4153.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: The use of anti-angiogenic therapies for the treatment of neovascular AMD has significantly increased the burden on healthcare providers due to the need for regular and repeated review. Methods that may allow monitoring to be carried out by community optometrists are therefore attractive as they could reduce the burden on secondary care. This study aimed to investigate whether relapse after Lucentis treatment could be reliably detected using PHP and visual acuity (VA) assessment alone without access to optical coherence tomography (OCT) data.

Methods: Twenty five patients with neovascular AMD who were within the Lucentis pathway and whose macula was confirmed fluid free were enrolled. PHP was performed at 3 consecutive follow-up appointments. The Optometrist used the PHP and VA data to decide if the patient required retreatment. This was compared with the decision made by an Ophthalmologist who used both OCT and VA.

Results: Of 30 decisions made during the follow-up period 24(80%) were concordant. Sensitivity was 73.3%, specificity 88.9%. Of those screened initially approximately 47% were unable to undertake the test reliably and therefore could not be enrolled in the study. The most common reason for unreliability was a slow reaction time by the patient to the presented stimuli (45%). This ultimately led to a high false positive score. Other contributing factors included arthritic and dexterity problems (17%) and poor VA (4%).

Conclusions: PHP may be useful to detect lesion reactivation in those patients who are able to complete the test reliably.

Keywords: 412 age-related macular degeneration  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×